News
It is hard to get excited after looking at Becton Dickinson's (NYSE:BDX) recent performance, when its stock has declined 24% over the past three months. We, however decided to study the company's ...
Medtronic is bringing on a medical device industry veteran for its new top lawyer as it prepares for a major organizational ...
Shares of Becton, Dickinson and Company (NYSE:BDX – Get Free Report) have been given an average recommendation of “Hold” by ...
The "Blood Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The global blood market is poised to expand by USD 2.59 billion from 2024 to 2029, with an anticipated CAGR of 5.7%.
Price Action: Starboard Value’s new stake in Tripadvisor Inc. led to an 8.07% increase in its closing price on July 2, reaching $14.99 according to Benzinga Pro data. The company is up 1.49% ...
To enable awareness and knowledge-sharing around best practices of atherothrombectomy in the treatment of vascular diseases a ...
Ivan Fong, 63, was one of the highest-proifile GCs to sign an amicus brief supporting Perkins Coie's legal challenge of ...
Enter Dividend Kings — stocks that have had their dividend payouts increased for 50 years or more consecutively. This article ...
Quantum eMotion Corp. is transitioning to commercializing QRNG cybersecurity tech in healthcare, fintech & more. Learn more ...
Review quarterly and annual revenue, net income, and cash flow for Becton Dickinson & Co (BDX:XNYS) stock through the last fiscal year.
Becton, Dickinson Down Over 13%, On Track for Largest Percent Decrease Since June 1999 — Data Talk Global News Select May 1, 2025, 9:05:00 AM Becton 2Q Net Down, Warns of Tariff Hit on 2025 EPS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results